AGISOL LLC holds $21.0M across 13 federal awards, concentrated at Department of Health and Human Services (HHS). This PIID sits alongside 1 related award under parent 47QTCB22D0589. The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Jan 20, 2027 PoP end — agencies typically plan 12–18 months ahead.
FIRM FIXED PRICE AWARD CENTER FOR DRUG EVALUATION AND RESEARCH (CDER) - REGULATORY REVIEW SYSTEMS ANALYSIS AND SUNSET SUPPORT CONTRACTING OFFICER REP (COR) JONATHAN RAPPAPORT TEL: 301-525-8444 JONATHAN RAPPAPORT@FDA.HHS.GOV CONTRACTING SPEC
Current PoP ends Jan 20, 2027 (170 days remaining). Agencies typically plan 12–18 months ahead — position before the PoP clock runs out.
Track recompete timing in SCOUT →AGISOL LLC — $21.0M obligated across 13 awards (firm-wide, all agencies).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Live Demand-Fit + Displacement scoring, alerts on verdict flips, and watchlists. 90 days · $90 · no annual contract · cancel anytime
See all live recompete landscapes — who else is expiring on OASIS+, and where the openings are.
Open AGISOL LLC’s federal contract profile — agency mix, recompete pipeline, and teaming relationships.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows. Explore it live — $90 Pilot →